A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers

Inclusion Criteria: * Between 20 aged and 50 aged in healthy adults * Weight more than 55kg, IBW 20% within the range * Agreement with written informed consent Exclusion Criteria: * Subject has hypersensitivity reaction or clinically significant history about investigational drug * Clinically significant cardiovascular system, respiratory system, liver, renal, endocrine system, gastrointestinal system, central nervous system, blood tumor, mental disease, skin disease and so on * Inadequate result of laboratory test * AST(SGOT) or ALT(SGPT) \> 1.5 x upper limit of normal range * Continued to be taking caffeine (caffeine \> 5 cup/day), drinking(alcohol \> 210 g/day) or during clinical trials can not be drunk or severe heavy smoker (cigarette \> 10 cigarettes per day) * Creatinine clearance \< 80ml/min * Subject with known for history(such as gastrointestinal disease or operation) with affect the absorption of drug * Subject takes an abnormal meal which affect the ADME of drug * Previously participated in other trial within 90 days * Previously make whole blood donation within 60 days or component blood donation within 30 days * Subject with positive reaction for reason of laboratory test result * An impossible one who participates in clinical trial by investigator's decision including for reason of laboratory test result